- Reported transaction lines
- 1
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| SMITH PATRICK W 10% owner · Insight Molecular Diagnostics Inc. | IMDX Insight Molecular Diagnostics Inc. | Other transactionFiling detailsSEC transaction code J Common Stock · Indirect ownership · See Footnote · Reported balance after transaction: 4401342 · Reflect shares of Insight Molecular Diagnostics Inc.'s (the "Issuer") common stock, no par value, purchased by the Reporting Person in an underwritten public offering of the Issuer at the public offering price of $1.75. · The shares of common stock reported herein are directly held by Patrick W Smith The Smith Irrevocable Trust U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust. | 2026-11-17 | 2026-11-20 | 1,142,857 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.